BioDatomics Launches New NGS Analysis Software, Announces Digicon Partnership | GenomeWeb

BioDatomics has launched a new commercial product for the next-generation sequence data analysis market — a software package called BioDT that the company claims is faster and much simpler to use than existing source software packages.

The Bethesda, Md.-based bioinformatics software developer launched BioDT last week during the American Society of Human Genetics meeting in Boston. It is based on technology that was first developed by BioDatomics CEO and founder Maxim Mikheev and colleagues at the Russian Academy of Sciences between 2002 and 2006.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.